Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations

BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease in the world. Progression toward non-alcoholic steatohepatitis (NASH) is associated with alterations of skeletal muscle. One plausible mechanism for altered muscle compartment in liver dis...

Full description

Bibliographic Details
Main Authors: Camille Pichon, Maxime Nachit, Justine Gillard, Greetje Vande Velde, Nicolas Lanthier, Isabelle A. Leclercq
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Nutrition
Subjects:
MAFLD (metabolic-associated fatty liver disease)
NASH (non-alcoholic steatohepatitis)
ammonia
myosteatosis
L-ornithine L-aspartate
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2022.1051157/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2022.1051157/full

Similar Items